Recent studies showing that the serine dipeptidases DPP8/9 inhibit activation of NLRP1 has put renewed interest in past studies on inhibitors of these peptidases (like talabostat) as anti‐tumor agents (Eager et al., 2009). Here, DPP8 is linked to neoplasm.